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Patients with acute rheumatic fever (ARF)' have been shown to have circulat-
ing heart-reactive antibodies (HRA), often in high titer, and examination of the
myocardium of some of these patients at autopsy has revealed the presence of
bound antibody and complement (1, 2). HRA in ARF have been shown by van
de Rijn et al. (4) to react with streptococcal membrane polypeptides, and they
have also been generated in rabbits immunized with group A streptococcal
membranes (3, 4). However, studies by Kaplan (5) have previously implicated
cell wall components and Mprotein ofgroup A streptococci in the immunologic
crossreactions between HRA and streptococcal antigens. Since M protein is the
major virulence determinant of group A streptococci, and since antibodies to
the M protein protect against infection with homologous type streptococci, the
production of a safe vaccine has been the purpose of innumerable studies of the
antigenic composition of Mproteins and their immunologic crossreactivity with
heart tissue (5-9). Analysis ofhomogeneous Mprotein preparations by Dale and
Beachey (6) revealed that M types 5 and 19 possess heart crossreactive epitopes,
and Poirer et al. (9) found that the cloned type 5 M protein gene produced M
protein that retained the epitopes that bind HRA. Type 1 M protein has also
been implicated in crossreactions with HRA (7, 8).
The results of these past studies support the hypothesis that at least some of
the M proteins, especially M type 5, share determinants with host antigens .
Furthermore, anti-M type 5 antibodies wereshown to reactwitha high molecular
weight sarcolemmal antigen (6), and structural studies of type 5 M protein by
Fischetti and Manjula (10, 11) have shown its structure to be similar to both
tropomyosin and myosin.
Other studies to determine the capacity ofantistreptococcal sera to react with
host tissues have shown that these antisera react not only with heart tissue but
also with skin (8), brain (12), skeletal muscle (3), and thymus (8). Fibroblasts have
also been shown (13) to absorb HRA from ARF sera, and streptococcal mem-
branes absorbed the antibodies that reacted with the fibroblasts. However, until
recently, the autoantigens involved in these crossreactions were unidentified.
Our studies have primarily focused on the use of anti-Streptococcus pyogenes
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mAbs as probes for the crossreactive antigens shared between the streptococcus
and human heart tissue. The reaction of these mAbs with heart tissue proteins
revealed a high molecular weight antigen that was subsequently identified as
myosin (14). In a study of the fragments of myosin, it was shown that crossreactive
sites resided in either the light or heavy meromyosin subfragments of the heavy
chain. In addition, the mAbs were found to be specific for either skeletal myosin
alone or for both cardiac and skeletal myosin (15) .
In this report, the mAbs that react with group A streptococci and myosin were
used as probes to identify additional crossreactive antigens in host tissues. One
of the streptococcal mAbs reacted with myosin, DNA, and synthetic nucleotide
homopolymers, and another crossreactive mAb was specific for myosin, keratin,
and actin, a family for a helical coiled-coil proteins.
The streptococcal antigens reactive with these antibodies in Western immu-
noblots were streptococcal membrane protein(s) and pep M5 protein extracts.
The present study describes the reactions of these crossreactive mAbs with both
streptococcal antigens and a variety of autoantigens, and we discuss the implica-
tions of these findings.
Materials and Methods
Streptococci.
￿
M type 5 Streptococcuspyogenes (manfraedo) was obtained from Edwin H.
Beachey, Veterans Administration Medical Center, Memphis, TN. Streptococci were
cultured at 37 °C in chemically defined medium (CDM), according to the method of van
de Rijn and Kessler (16).
Streptococcal Membranes.
￿
Membranes were purified from whole streptococci broken
with sterile glassbeads in a Bronwill cell homogenizer (Bronwill Scientific, Inc., Rochester,
NY [17]). Purification included differential centrifugation with a final centrifugation at
100,000 g, as previously described (18).
Chemicals.
￿
Poly(A), Poly(C), Poly(U), Poly(1), Poly(dT), and Poly(dA) were from P-L
Biochemicals, Inc., Milwaukee, Wisconsin. Calf thymus DNA and histones were obtained
from Calbiochem-Behring Corp., La Jolla, California. BSA (fatty acid- and globulin-free),
egg white lysozyme, human epidermal keratin, rabbit heart actin, beef heart cardiolipin,
rabbit skeletal muscle myosin, PC, and human and mouse IgG were from Sigma Chemical
Co., (St. Louis, MO) and calf skin collagen was from Worthington Biochemical Corp.,
Freehold, NJ.
Pepsin-extracted M Protein.
￿
-30 grams of group A, M type 5 streptococci, cultured in
CDM and washed twice in PBS, were treated with pepsin at pH 5.8 according to the
method of Manjula and Fischetti (19). Streptococci were washed twice in sodium phosphate
buffer, pH 5.8, and were suspended at a concentration of 1 g of organisms per 2 ml of
buffer. The cell suspension was warmed to 37'C and pepsin was added at a concentration
of 1 mg per 10 g of bacteria. Digestion was performed at 37°C with slow stirring, and
after 45 min pepsin activity was neutralized by adding sodium bicarbonate to raise the
pH to 7.4 at 0° C. The suspension was centrifuged at 15,000 rpm for 15 min, and the
supernatant was collected. The streptococci were resuspended in phosphate buffer, pH
5.8, and the digestion procedure was repeated. Supernatants from the first and second
digestions were sterilized by filtration through a 0.22 km Millipore filter and were kept
separated. The supernatants were concentrated by ultrafiltration through a PM 10 mem-
brane (Amicon Corp., Danvers, MA), were stored at 4°C, and were tested for reactivity
with anti-S. pyogenes M type 5 sera kindly provided by Dr. Richard Facklam (Centers for
Disease Control, Atlanta, GA .). Purity of the preparations was determined by SDS-PAGE
and Western immunoblotting.
Monoclonal Antibodies.
￿
Murine hybridoma cell lines were selected, cloned, stored and
maintained as previously described (20). mAbs used in this study included 36.2.2, 49.8.9,1000 POLYSPECIFIC ANTISTREPTOCOCCAL MONOCLONAL ANTIBODIES
and 54 .2.8, which were stored as culture fluids at 4°C. Characteristics of these mAbs
have been reported elsewhere (14, 18, 20).
ELISA, Competitive Inhibition Assays, and Western Immunoblotting. The ELISA was
performed according to methods previously described (20). The ELISA was used to
determine reactions of the mAbs with M type 5 S. pyogenes, glutaraldehyde-fixed to
polyvinyl chloride microtiter plates. In competitive inhibition assays, which have been
previously described (15), antibodies were mixed 1 :1 with increasing concentrations of
inhibitor and incubated 1 h at 37°C and overnight at 4° C. The antibody was then mixed
in duplicate with M type 5 S. pyogenes attached to microtiter plates, and the ELISA was
performed as previously described (20).
Western immunoblots were performed according to the method of Towbin et al . (21)
and PAGE was performed in gradient gels according to the method of Laemmli (22). 10-
20% slab gel gradients were prepared from an acrylamide stock solution containing 30 g
acrylamide (Sigma Chemical Co.) in 100 ml distilled water. Gradients were prepared by
mixing solutions in a gradient maker. The 10% acrylamide solution contained 6.66 ml of
the acrylamide stock solution, 0.4 ml glycerol, 2.5 ml of 1 .5 M Tris-HCl buffer (pH 8.9),
9.96 ml distilled water, 0.2 ml 10% SDS, 0 .008 ml TEMED, and 0.135 ml freshly
prepared ammonium persulfate. The 20% acrylamide solution was prepared by mixing
13 .34 ml of the acrylamide stock solution with 2.4 ml glycerol, 2.5 ml of 1 .5 M Tris-HCl
buffer (pH 8.9), 0.46 ml distilled water, 0.20 ml 10% SDS, 0.002 ml TEMED, and 0.05
ml freshly prepared 10% ammonium persulfate. The stacking gel was prepared by mixing
1 .5 ml of acrylamide stock solution with 1 .25 ml of 0.5 M Tris-HCl buffer (pH 6.8), 7.10
ml distilled water, 0.10 ml 10% SDS, 0.005 ml TEMED, and 0.1 ml of freshly prepared
10% ammonium persulfate.
Before loading onto polyacrylamide gels, samples were boiled for 3-5 min in 1-5%
SDS and 10% 2-ME in Tris buffer (pH 7.2) containing glycerol and bromphenol blue
tracking dye. Samples were separated by electrophoresis for 4-6 h at 35 mA per gel slab
and then were electroblotted against nitrocellulose membranes (0.45 um) for 18 h at 80
mA. A portion of each blot was stained for protein with amido black in acetic acid and
methanol, as previously described (18). Culture fluids containing mAbs were mixed with
the other portions of the blot, and antibody reactivity was detected by peroxidase-
conjugated anti-mouse IgM (Cappel Laboratories, Cochranville, PA) and subsequent
development in the substrate H202 and chloronaphthol, as described before (18). Blots
were dried and photographed. Molecular weights of proteins were estimated using
molecular weight marker standards (Sigma Chemical Co.)
Human Cell Lines and Cultures.
￿
Human skin fibroblasts were obtained from the skin
of normal human volunteers. The dermis obtained from punch biopsy specimens was
dissected free of epidermis and plated into six-well tissue culture plates (Costar, Cam-
bridge, MA) with DMEM plus 10% FCS, 100 U/ml penicillin, 0.1 mg/ml streptomycin,
and 2 MM L-glutamine. Fibroblasts grew preferentially and were identified by their
morphology and staining leucine aminopeptidase activity (23). The A431 squamous
carcinoma and the A549 lung carcinoma cell lines were obtained from American Type
Culture Collection (Rockville, MD) and were maintained in DMEM with 10% FCS,
penicillin (100 U/ml), streptomycin (0.1 mg/ml), and 2 MM L-glutamine. Cells were grown
to confluence on sterile coverslips, washed in PBS, fixed in cold acetone, dried and stored
dessicated at -20 °C until used.
Immunofluorescence Staining ofCell Lines.
￿
Cells fixed on coverslips were rehydrated in
PBS, and covered with 200 Al of culture fluid containing the appropriate mAb. After a
30 min incubation at room temperature, the coverslips were then washed in PBS, and
200 jul of fluorescein-conjugated anti-mouse IgM (Cappel Laboratories) diluted 1 :15 in
PBS was applied to each coverslip and incubated at room temperature for 30 min. The
coverslips were again washed in PBS, mounted on glass slides with PBS-glycerin, and read
on a Laborlux microscope (E. Leitz, Rockleigh, NJ) equipped with epifluorescence. A549
cells were examined for the presence of keratin intermediate filaments by incubation of
fixed cells with guinea pig anti-cow prekeratin antisera (Miles Laboratories, Inc., Naper-
ville, IL) diluted 1 :10 in PBS for 30 min at room temperature followed by fluorescein-CUNNINGHAM AND SWERLICK
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conjugated goat anti-guinea pig Igs (U. S. Biochemical Corp., Cleveland, OH). As positive
and negative controls, A431 cells and human fibroblasts were examined using anti-
prekeratin antisera.
Antibody Blocking Studies Using Anti-Vimentin Antibodies.
￿
200 Al of rabbit anti-human
vimentin antisera (Transformation Research, Cambridge, MA.), diluted 1 :5 in PBS, was
placed on coverslips containing fixed human fibroblasts, and was incubated for 30 min at
room temperature. After three washes in PBS, the coverslips were incubated with mAb
54.2 .8 for 30 min, washed in PBS, and then incubated with fluorescein-labeled goat anti-
rabbit Ig (U . S. Biochemical Corp.). After a 30 min incubation at room temperature,
coverslips were again washed in PBS, mounted in PBS/glycerin, and examined for
fluorescence.
Results
Antistreptococcal Activity ofmAbs.
￿
Mouse hybridomas secreting antibodies that
bind to group A streptococci were selected as previously described (20). Two
(36.2 .2 and 54.2.8) of this group of hybridomas producing antibodies crossreac-
tive with heart and streptococci were found to react with myosin (14). One mAb
(49.8.9) that did not react with myosin but was crossreactive with human heart
extracts has continued to be studied and is included herein. All three niAbs
antibodies are the IgM isotype.
We tested the mAbs for binding to streptococcal antigens in the Western
immunoblot. Whole group A, M type 5 streptococci and their membranes were
extracted with 5% SUS, and the supernatants containing streptococcal antigens
were separated by PAGE and were electroblotted onto nitrocellulose membranes.
The blots were subsequently reacted with the mAbs and a normal mouse IgM
(20 Ag/ml) control. Fig. 1 illustrates the results of this experiment. mAbs 36 .2.2,
49.8 .9, and 54.2 .8 all reacted with several streptococcal antigen(s) of high
molecular weight and with a triplet of bands near 58,000 . Purified M type 5
streptococcal membranes were also treated with 5% SDS and compared with the
whole cell extracts. mAbs 36 .2.2 and 54 .2.8 reacted strongly with a membrane
antigen near 62,000-67,000 . These results demonstrate that the antibodies
reacted simultaneously with components from whole cells and membranes.
Since the triplet of bands in streptococcal whole cell extracts corresponded to
the molecular size of M protein, pepsin extracts of M type 5 S. pyogenes were
separated by electrophoresis and electroblotted onto nitrocellulose. The protein
from the first extraction contained only peptides of type 5 M protein based on
their positive reaction with M type 5-specific antisera (a generous gift of Dr.
Richard Facklam, Centers for Disease Control) . The larger fragment of the pep
M 5 protein preparation reacted with mAbs 36 .2 .2 and 54.2.8 in the Western
immunoblot (Fig . 2) . The reaction of these mAbs with a similar sized band was
seen when purified pep M 5 (obtained as a generous gift from Dr . Edwin Beachey,
Veterans Administration Medical Center, Memphis, TN) was used as antigen.
To test another type of M protein, cloned M 6 protein from S. pyogenes was
obtained as a generous gift from Dr. Vincent Fischetti (The Rockefeller Univer-
sity). Both pep M 5 and the cloned M 6 proteins were attached to ELISA plates,
and mAbs 36.2 .2, 54 .2.8, and 49 .8 .9 were mixed with both M types. mAbs
25.3 .10 and 25 .5 .3 (IgM isotype) were included as control antibodies that react
with group A streptococci but are essentially unreactive with the M protein . In
the ELISA, mAbs 36.2 .2 and 54.2.8 reacted with both pep M 5 and the cloned1002 POLYSPECIFIC ANTISTREPTOCOCCAL MONOCLONAL ANTIBODIES
FIGURE 1 .
￿
Western immunoblot of SDS-extracted, M type 5 S . pyogenes membranes (MB or
left lane) and whole cells (WC or right lanes) after separation in a 10-20% slab gel gradient by
SDS-PAGE . Electroblotted MB and WC proteins were mixed separately with amido black
(STAIN) mAbs 36.2.2, 49.8.9, 54.2.8, and a medium control containing mouse IgM (18
rug/ml) . Stained molecular mass markers (x 10') are shown (STD) for : myosin, 200 ; fl-
galactosidase, 116 ; phosphorylase B, 94 ; BSA, 67 ; egg albumin, 43 ; and carbonic anhydrase,
30 .
M 6 proteins, while 49.8 .9 reacted only with the pep M 5 (Table I) . None of
these antibodies was opsonic for M type 5 S. pyogenes (data not shown) . The
capacity of 49 .8.9 to react with pepM 5 in the ELISA, but not in the Western
immunoblot, suggests that the epitope is labile to SDS treatment .
Evaluation of the Binding ofmAbs to Human Cell Lines by Indirect Immunofuores-
cence. Since fibroblasts were previously shown (13) to absorb HRA from ARF
sera, human skin fibroblasts were mixed with mAbs 36.2 .2, 49 .8.9, and 54.2 .8
in an attempt to examine their crossreactive antigens . All three of the mAbs
reacted distinctly with the fibroblasts (Fig. 3) . mAb 36.2.2 reacted with cyto-
plasmic cytoskeletal elements, as did 49 .8 .9 (Fig . 3, a and b) . However, 54.2 .8
reacted strongly with both the nucleus and cytoskeletal structures in the cyto-
plasm (Fig . 3c) . Similar nuclear fluorescence was observed when 54.2.8 was
reacted with A431 squamous carcinoma line (Fig . 4a), but filamentous cyto-
plasmic staining was not prominent when these cells were reacted with any of
the mAbs . The A549 tumor cell line, an epithelioid cell line derived from a
human lung carcinoma, also showed nuclear staining upon reaction with 54.2.8,
and cytoplasmic filamentous staining upon reaction with 49.8 .9, but the most
striking reactivity was noted with mAb 36.2 .2 (Fig . 4c) . No nuclear fluorescenceCUNNINGHAM AND SWERLICK
FIGURE 2 .
￿
Western immunoblot ofM type 5 protein extractedwith pepsin (Pep M-5) after
separation in a 10-20% slab gel gradient by SDS-PAGE .PepM-5 protein wasmixed separately
with amidoblack(STAIN) mAbs 36.2.2,49.8.9, and 54.2.8, anda medium control containing
mouse IgM (18 Ag/ml) . Stained molecular mass markers (X 10-5) areshown (STD) for: myosin,
200; 0-galactosidase, 116 ; phosphorylase B, 94 ; BSA, 67 ; egg albumin, 43 ; and carbonic
anhydrase, 30 .
TABLE I
Comparison ofthe BindingofHeart-crossreactive mAbs with PepM 5
and ClonedM 6 Proteins in ELISA
The cloned M6 was a generous gift from Dr. Vincent A. Fischetti, The
Rockefeller University, New York .
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was seen, but cytoskeletal elements were brightly labeled . No fluorescence was
seen with fibroblasts (Fig . 3d), A549 (Fig . 4d), or A431 (Fig . 4b) cells when
they were mixed with normal mouse IgM (10 tLg/ml) control medium . Both
A431 and A549 cell lines stained positively with anti-keratin serum, but fibro-
blasts did not (data not shown) .
Since fibroblasts contain vimentin as a major cytoskeletal element in the
cytoplasm, mAb 54.2.8 was challenged with rabbit anti-vimentin sera for binding
of the fibroblast cytoskeleton . Fig . 5 a shows that normal rabbit sera did not
affect the reaction of 54 .2 .8 with the fibroblasts, whereas anti-vimentin sera
Hybridoma clone
Pep M-5
OD405
Cloned M-6
36.2.2 1 .819 1.378
49.8.9 1 .076 0.291
54.2.8 1 .034 1.417
25.5 .1 .4 0 .287 0.118
25.3 .1 .9 0.269 0 .150
Medium control 0.017 0 .024
PBS control 0.000 0 .0071004 POLYSPECIFIC ANTISTREPTOCOCCAL MONOCLONAL ANTIBODIES
FIGURE 3.
￿
Indirect immunofluorescence after the reaction of mAb 36.2.2 (a), 49.8.9 (b),
54.2.8 (c), andmedium plus mouseIgM(10 tag/ml) (d) with cultured normal human fibroblasts .
Original magnification, X 150 .
clearly blocked the reaction of 54.2.8 with the cytoplasm while leaving the
nuclear staining unchanged (Fig . 5 b) . Disruption of fibroblasts in PBS containing
proteinase inhibitors released proteins in the 55,000-65,000 range, near the
molecular weight ofvimentin (58,000), that reacted with mAb 54.2.8 in Western
immunoblots (data not shown) .CUNNINGHAM AND SWERLICK
￿
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FIGURE 4 .
￿
Indirect immunofluorescence after the reaction of mAb 54.2.8 (a) and control
medium containing normal mouse IgM (10 jug/ml) (b) with the cultured A431 cell line (original
magnification X 100 and X 150, respectively) . Reaction ofmAb 36.2.2 (c) and normal mouse
IgM in control medium (d) with the cultured A549 cell line (original magnification, X 250
and x 50, respectively).
Competitive Inhibition of mAbs by Multiple Autoantigens .
￿
Since mAb 54.2.8
reacted with the nucleus of fibroblasts, it was important to determine whether
or not the reaction was, in fact, with DNA or with nuclear proteins or histories .
We tested cardiolipin, PC, myosin, and BSA, in addition to calf thymus DNA,1006 POLYSPECIFIC ANTISTREPTOCOCCAL MONOCLONAL ANTIBODIESTABLE 11
Competitive Inhibition of mAbs 36.2.2, 49.8.9, and 54.2.8 by Calf
Thymus DNA, SyntheticPolynucleotides, and Myosin
CUNNINGHAM AND SWERLICK
* Concentration of mAb producing 50% inhibition of the antibody reac-
tivity with M type 5 group A streptococci in ELISA (A4os). Concentra-
tions>250-500 gg/ml were not tested.
TABLE III
Competitive Inhibition of mAb 36.2.2, 49.8.9 and 54.2.8 by a
Number of Coiled-coiled Proteins and IgG
* Concentration of mAbproducing 50% inhibition of the antibody reac-
tivity with M type 5 groupA streptococci in the ELISA (A4os). Concen-
trations >250-500 Ag/ml were not tested.
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synthetic nucleotide homopolymers, poly(A), poly(C), poly(U), poly(I), poly(dT),
poly(dA), and histones in competitive inhibition assays (Table 11). mAbs were
incubated with each inhibitor and then mixed in the ELISA with group A, M
type 5 streptococci. Calf thymus DNA was a strong inhibitor of mAb 54.2 .8 as
was poly(I) and myosin. Poly(dT) was inhibitory at 87 gg/ml, and cardiolipin was
less inhibitory at ? 125 jug/ml. mAbs 36 .2 .2 and 49 .8.9 were unaffected by DNA
and did not react with the synthetic homopolymers. Myosin as the positive
control inhibited antibodies 36.2 .2 and 54 .2.8 as expected, and BSA served as a
negative control. Histories and PC did not react with any of the mAbs.
The mAbs were mixed with a helical coiled-coil proteins and IgG (Table 111).
Myosin was used as the positive control, while BSA and lysozyme were negative
Inhibitor
Concentration (jug/ml)
36 .2.2 49.8.9
of mAb:*
54.2.8
Calf thymus DNA >500 >500 3.9
Poly(A) ND ND >500
Poly(C) ND ND >500
Poly(U) ND ND 500
Poly(I) ND ND 7
Poly(dA) ND ND >500
Poly(dT) ND ND 87
Myosin 31 >500 15
BSA >500 >500 >500
Histories >500 500 >500
Cardiolipin 250 >500 62-125
Phosphoryl choline >500 >500 >500
Inhibitor
Concentration (,ug/ml)
36.2.2 49.8.9
mAb:*
54.2.8
Myosin 31 >500 15
Keratin 0.97 >500 250
Actin 0.18 >500 500
Collagen >500 >500 >500
BSA >500 >500 >500
Lysozyme >500 >500 >500
Human IgG >500 500 >500
Mouse IgG >500 >500 >5001008 POLYSPECIFIC ANTISTREPTOCOCCAL MONOCLONAL ANTIBODIES
controls. IgG from both mouse and human was tested in the competitive
inhibition assays to determine the presence of rheumatoid factor antibodies.
Keratin, actin, and collagen were also tested for reactivity with the crossreactive
mAbs. Both keratin and actin strongly inhibited mAb 36 .2.2, but they had little
affect on antibodies 49.8.9 and 54.2 .8. Collagen failed to inhibit any of the
antibodies. None of the crossreactive antibodies were rheumatoid factors since
they were not inhibited with mouse or human IgG. BSA and lysozyme had no
affect as negative controls. The results show that the mAbs are not rheumatoid
factors; that 36 .2.2 is specific for a helical coiled-coil proteins such as myosin,
actin, and keratin; and that 54 .2.8 is an anti-DNA antibody.
Discussion
The presence of HRA in the sera of ARF patients has been a concern for
several decades, and it has prompted investigators to identify streptococcal and
host antigens that may participate in the disease process. For this reason, the
most recent studies have focused on characterizing the antigens involved in the
crossreactions between streptococci and heart tissue (14, 15, 18, 20). In our
studies (14, 15, 18) and those of other investigators (4, 6) the cross reactive
antigens of the streptococcus are found associated with membrane protein(s) and
the major virulence determinant, M protein.
For this study, we chose M type 5 group A streptococci because of its frequent
association with cases of rheumatic heart disease (24). The production and use
of crossreactive murine mAbs as probes has been our strategy to resolve the
identity of host and streptococcal antigens that immunologically crossreact. This
approach led us to the identification ofmyosin as one oftheautoantigens involved
in these cross reactions. The stimulation of B cell clones against myosin by the
streptococci is an attractive hypothesis for the production of cross reactive auto-
antibodies. This hypothesis is consistent with the work of Fischetti and Manjula
(10, 11), which has shown that type 5 M protein resembles the structure of
myosin, and the work of Dale and Beachey (25), which has shown that anti-
myosin antibody from ARF sera reacts with type 5 M protein.
Additional information about the specificity of our antistreptococcal mAbs has
been presented herein and indicates that, in fact, the mAbs crossreactive with
streptococci and myosin do react with a 54,000-56,000 mol wt piece of Pep M
5 protein, perhaps a dimer. The only other possible explanation of the larger-
sized fragment is that it could be a protein sharing epitopes with M protein. This
evidence does not preclude the reactivity of these antibodies with a 62,000-
67,000 mol wt protein in the type 5 membrane preparations. Whether or not
the membrane protein is part of the M protein molecule buried in the membrane
is not yet clear. It is evident that our mAb reacted with both. These results may
help to explain why there have been coincident and conflicting reports about
the heart crossreactive antigens in both the cell wall and membrane preparations
of group A streptococci (3, 5). Since small pieces of M protein were not strongly
reactive with the mAbs, the M protein epitope may be associated with a confor-
mational determinant, the dimeric form, or both. Alternatively, the epitopes
reactive with our mAbs may be primarily confined to the carboxyl terminus of
M protein and seen only on the largest piece of the pep M protein, since pepsinCUNNINGHAM AND SWERLICK
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extraction primarily cleaves the amino terminal half of the molecule, leaving
behind the carboxy terminal residues. Conserved epitopes have been shown (26)
to reside in the carboxyl terminus of M protein . This might explain the case for
mAb 36.2 .2 and 54.2.8, which reacted with both the pep M 5 and the whole M6
molecule, whereas 49.8 .9 reacted only with pep M 5 in the ELISA . Further
studies are in progress to elucidate the nature of these epitopes.
The most intriguing findings in this report center around the autoantigens, in
addition to myosin, that react with these antistreptococcal mAbs. The most
recent work by Fischetti and Manjula (10, 11) on the structure of streptococcal
M proteins has identified them as a helical coiled-coil structures with a seven
amino acid residue periodicity similar to that of tropomyosin, myosin, and the
desmin-keratin family of a helical proteins. The results obtained with the mAb
probes used in this study suggest that the crossreactive autoantigens are a family
of a helical proteins or DNA .
There are very few studies of the presence of anti-DNA antibodies in ARF,
but one study reported (28) that 29% of the ARF patients tested were antinuclear
antibody (ANA)-positive. Another study of anti-DNA murine mAbs produced
from mice susceptible to systemic lupus erythematosus reacted with endogenous
bacteria, including Streptococcus faecalis (29). Some of these antibodies also
reacted with the nucleus and with poly(I), poly(dT), and cardiolipin (30, 31).
The antibodies found in mice susceptible to systemic lupus erythematosus ap-
peared to be similar in activity to 54.2.8, and it could be speculated that they
come from the same types of B cell clones. One report (31) has recently described
an mAb to myosin that reacted with DNA, but whether or not it was an
antibacterial antibody was not investigated. Since anti-DNA or antinuclear anti-
bodies have been reported in autoimmune disorders (32), the amplification of
antibody-producing clones directed at self antigens by infectious agents or
microorganisms is a possible mechanism for the production of some of the
autoantibodies (29, 33).
In conclusion, our studies provide definitive evidence that antistreptococcal
mAbs react with streptococcal type 5 M protein and an unidentified streptococcal
membrane protein(s), and with multiple autoantigens including DNA, myosin,
keratin, and other a helical coiled-coil proteins. It is clear that the mAbs 36.2 .2
and 54.2.8 have different specificities and that further investigation of crossreac-
tive epitopes of the streptococcus and peptides of the a helical coiled-coil proteins
such as myosin and M protein will be important in understanding the role of the
streptococcus in the production of autoantibodies in rheumatic heart disease.
Summary
mAbs produced by immunization of BALB/c mice with Streptococcus pyogenes
M type 5 membranes were further characterized for their reaction with S.
pyogenes pep M5 protein and with autoantigens associated with human cell lines.
mAbs 36.2.2 and 54.2 .8 simultaneously reacted with M protein and a membrane
protein(s) of S. pyogenes. When cell lines were mixed with 54.2 .8, we saw nuclear
fluorescence along with staining of the cytoskeleton. Subsequent experiments
revealed that 54.2 .8 was an anti-DNA antibody that reacted with DNA, poly(I),
poly(dT), and weakly with cardiolipin. Its reactivity with the cytoskeleton could101 0 POLYSPECIFIC ANTISTREPTOCOCCAL MONOCLONAL ANTIBODIES
be blocked with anti-vimentin . On the other hand, 36.2.2 reacted with the
cytoskeleton, sparing the nucleus, and was inhibited by the a helical proteins
myosin, actin, and keratin. mAb 54.2.8 was inhibited with myosin, but not with
actin and keratin. None of the antibodies studied were inhibited by collagen,
and none of them were rheumatoid factors. The results imply that Group A
streptococci can activate B cell clones against myosin, a helical proteins, or DNA,
thereby contributing to the enhancement of autoantibody production.
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